ESC 2025 MADRID

ESC Congress 2025 together with World Congress of Cardiology!

The spotlight will be “Global Health”, as we explore cardiology without borders, highlighting the shifting role of cardiovascular disease within the broader global health landscape.

ESC Congress 2025 together with World Congress of Cardiology is a milestone, celebrating 75 years of the ESC. Together with the World Heart Federation (WHF), they will unite our diverse community to share knowledge, innovation, and expertise from every continent.

As always, ISCP will be actively involved, contributing to the largest event in cardiology with impactful presentations, discussions, and networking opportunities. We can’t wait to connect—Visit us at our Booth #B223!

You can find us in the International Associations & Publishers Row within the Exhibition West Hall. Our experts will be on hand to discuss the latest in cardiovascular pharmacotherapy and to answer any questions you may have. Whether you’re interested in the latest research, upcoming events, or simply want to network with peers, our booth is the place to be.

Highlight Session: The Therapeutic Conundrum in HFpEF

We invite you to attend our Official Joint Session with ESC:

• Title: The therapeutic conundrum in HFpEF
• When: Friday 30th August, 11:00 – 12:00 CEST
• Where: Room BAKU (Hall 4 – IFEMA MADRID)
• Session Type: Official Joint Session
• Track: Chronic Heart Failure

This session will be chaired by our President-Elect Prof. Doreen Tan (National University of Singapore), who will be joined by our long standing Board Members, Prof. Gheorghe Andrei Dan (Romania) and Prof. Koji Hasegawa (Japan).

Join leading international experts to explore mechanisms and treatment options for heart failure with HFpEF, a major challenge in modern cardiology. Discover new insights into SGLT2 inhibitors, mineralocorticoid receptor antagonists, anti-inflammatory therapy, and GLP-1/GIP pharmacology.

Programme:

• 11:00 – Mechanistic insights of SGLT2 inhibitors effectiveness
  Speaker: Gheorghe Andrei Dan, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
• 11:15 – Mineralocorticoid receptor antagonist drugs in HFpEF
  Speaker: Shelley Zieroth, University of Manitoba, Winnipeg, Canada
• 11:30 – Pharmacotherapy targeting inflammation in HFpEF
  Speaker: Koji Hasegawa, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
• 11:45 – GLP-1 receptor agonist (GLP1-RA) and gastric inhibitory polypeptides (GIPs) in HFpEF
  Speaker: Theresa McDonagh, King’s College Hospital, London, United Kingdom

Don’t miss the opportunity to deepen your understanding of HFpEF therapy with global thought leaders!

>>>Did you visit our booth at ESC 2024 in London? this is what we were up to!